Find Research Outputs

Search concepts
Selected filters

Publication Year

  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011

Author

  • Toshihiro Miyamoto
2015

[Allogeneic hematopoietic stem cell transplantation for multiple myeloma]

Takase, K. & Miyamoto, T., Jan 1 2015, In : Nihon rinsho. Japanese journal of clinical medicine. 73, 1, p. 107-113 7 p.

Research output: Contribution to journalArticle

2013
2015

Identification of TIM-3 as a Leukemic Stem Cell Surface Molecule in Primary Acute Myeloid Leukemia

Kikushige, Y. & Miyamoto, T., Jan 1 2015, In : Oncology. 89, p. 28-32 5 p.

Research output: Contribution to journalReview article

10 Citations (Scopus)
2014

[Treatment strategy for myeloproliferative neoplasms]

Yoshimoto, G. & Miyamoto, T., Oct 1 2014, In : [Rinsho ketsueki] The Japanese journal of clinical hematology. 55, 10, p. 1841-1852 12 p.

Research output: Contribution to journalReview article

Hematopoietic stem cell aging and chronic lymphocytic leukemia pathogenesis

Kikushige, Y. & Miyamoto, T., Oct 9 2014, In : International journal of hematology. 100, 4, p. 335-340 6 p.

Research output: Contribution to journalReview article

12 Citations (Scopus)
2013

Lymphoma (Following autologous stem cell transplant) surveillance counterpoint: Japan

Miyamoto, T., Jan 1 2013, Patient Surveillance After Cancer Treatment. Humana Press Inc., p. 471-473 3 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Detection of minimal residual disease in patients with multiple myeloma using clonotype-specific PCR primers designed from DNA extracted from archival bone marrow slides

Takamatsu, H., Ogawa, Y., Kobayashi, N., Obata, K., Narisawa, T., Nakayama, K., Munemoto, S., Aoki, G., Ohata, K., Kumano, Y., Ozaki, J., Murata, R., Kondo, Y., Terasaki, Y., Kurokawa, T., Miyamoto, T., Shimizu, N., Fukushima, T., Yoshida, A., Ueda, T. & 2 others, Yoshida, T. & Nakao, S., Oct 1 2013, In : Experimental Hematology. 41, 10, p. 894-902 9 p.

Research output: Contribution to journalArticle

4 Citations (Scopus)

Acquired haemophilia treated successfully with rituximab in a patient with pemphigus vulgaris

Chiba, T., Tsuji, G., Mitoma, H., Takahara, M., Moroi, Y., Miyamoto, T. & Furue, M., Mar 1 2013, In : Haemophilia. 19, 2, p. e98-e99

Research output: Contribution to journalLetter

4 Citations (Scopus)
2012

Treatment choice of immunotherapy or further chemotherapy for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis

Shiraishi, A., Ohga, S., Doi, T., Ishimura, M., Takimoto, T., Takada, H., Miyamoto, T., Abe, Y. & Hara, T., Aug 1 2012, In : Pediatric Blood and Cancer. 59, 2, p. 265-270 6 p.

Research output: Contribution to journalArticle

18 Citations (Scopus)

Initial low-dose valganciclovir as a preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients

Takenaka, K., Nagafuji, K., Takase, K., Kamimura, T., Mori, Y., Ito, Y., Nishi, Y., Henzan, H., Kato, K., Harada, N., Eto, T., Miyamoto, T., Teshima, T. & Akashi, K., Jul 1 2012, In : International journal of hematology. 96, 1, p. 94-100 7 p.

Research output: Contribution to journalArticle

8 Citations (Scopus)
2017

Recurrent subcutaneous sweet’s disease in a myelofibrosis patient treated with ruxolitinib before allogeneic stem cell transplantation

Sakoda, T., Kanamitsu, Y., Mori, Y., Sasaki, K., Yonemitsu, E., Nagae, K., Yoshimoto, G., Kamezaki, K., Kato, K., Takenaka, K., Miyamoto, T., Furue, M., Iwasaki, H. & Akashi, K., Jan 1 2017, In : Internal Medicine. 56, 18, p. 2481-2485 5 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)
2015

CD41 marks the initial myelo-erythroid lineage specification in adult mouse hematopoiesis: Redefinition of murine common myeloid progenitor

Miyawaki, K., Arinobu, Y., Iwasaki, H., Kohno, K., Tsuzuki, H., Iino, T., Shima, T., Kikushige, Y., Takenaka, K., Miyamoto, T. & Akashi, K., Mar 1 2015, In : STEM CELLS. 33, 3, p. 976-987 12 p.

Research output: Contribution to journalArticle

27 Citations (Scopus)

Successful treatment of adult Langerhans cell histiocytosis with intensified chemotherapy

Minami, M., Shima, T., Kato, K., Yamamoto, H., Tsuchihashi, K., Oku, S., Shimokawa, T., Tochigi, T., Yoshimoto, G., Kamezaki, K., Takenaka, K., Iwasaki, H., Oda, Y., Miyamoto, T. & Akashi, K., Aug 11 2015, In : International journal of hematology. 102, 2, p. 244-248 5 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)
2014

Successful treatment of invasive zygomycosis based on a prompt diagnosis using molecular methods in a patient with acute myelogenous leukemia

Yuda, J., Kato, K., Kikushige, Y., Ohkusu, K., Kiyosuke, M., Sakamoto, K., Oku, S., Miyake, N., Kadowaki, M., Iino, T., Tanimoto, K., Takenaka, K., Iwasaki, H., Miyamoto, T., Shimono, N., Teshima, T. & Akashi, K., 2014, In : Internal Medicine. 53, 10, p. 1087-1091 5 p.

Research output: Contribution to journalArticle

4 Citations (Scopus)
2011

Clonal origin of Epstein-Barr virus (EBV)-infected T/NK-cell subpopulations in EBV-positive T/NK-cell lymphoproliferative disorders of childhood

Ohga, S., Ishimura, M., Yoshimoto, G., Miyamoto, T., Takada, H., Tanaka, T., Ohshima, K., Ogawa, Y., Imadome, K. I., Abe, Y., Akashi, K. & Hara, T., May 1 2011, In : Journal of Clinical Virology. 51, 1, p. 31-37 7 p.

Research output: Contribution to journalArticle

13 Citations (Scopus)
2019

Usefulness of medication instruction sheets for sharing information on cancer chemotherapy within the health care team

Uchida, M., Nakamura, T., Watanabe, H., Kato, K., Miyamoto, T., Akashi, K. & Masuda, S., Jan 1 2019, In : Pharmazie. 74, 9, p. 566-569 4 p.

Research output: Contribution to journalArticle

A phase II study of lenalidomide consolidation and maintenance therapy after autologous PBSCT in patients with multiple myeloma

on behalf of the Japan Study Group for Cell Therapy and Transplantation (JSCT), Jan 22 2019, In : International journal of hematology. 109, 1, p. 107-114 8 p.

Research output: Contribution to journalArticle

4 Citations (Scopus)
2015

Effects of conditioning intensity in allogeneic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia

Takashima, S., Miyamoto, T., Kamimura, T., Yoshimoto, G., Yoshida, S., Henzan, H., Takase, K., Kato, K., Ito, Y., Ohno, Y., Nagafuji, K., Eto, T., Teshima, T. & Akashi, K., Dec 1 2015, In : International journal of hematology. 102, 6, p. 689-696 8 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)
2016

Enhanced Reconstitution of Human Erythropoiesis and Thrombopoiesis in an Immunodeficient Mouse Model with KitWv Mutations

Yurino, A., Takenaka, K., Yamauchi, T., Nunomura, T., Uehara, Y., Jinnouchi, F., Miyawaki, K., Kikushige, Y., Kato, K., Miyamoto, T., Iwasaki, H., Kunisaki, Y. & Akashi, K., Sep 13 2016, In : Stem Cell Reports. 7, 3, p. 425-438 14 p.

Research output: Contribution to journalArticle

9 Citations (Scopus)
2019

Risk of secondary primary malignancies in multiple myeloma patients with or without autologous stem cell transplantation

For the Fukuoka Blood and Marrow Transplantation Group, Jan 22 2019, In : International journal of hematology. 109, 1, p. 98-106 9 p.

Research output: Contribution to journalArticle

2011

[Specific surface markers of AML-leukemic stem cells].

Kikushige, Y., Miyamoto, T. & Akashi, K., Jul 1 2011, In : [Rinshō ketsueki] The Japanese journal of clinical hematology. 52, 7, p. 531-534 4 p.

Research output: Contribution to journalReview article

2018
1 Citation (Scopus)
2013

Autologous peripheral blood stem cell transplantation with granulocyte colony-stimulating factor combined conditioning regimen as a postremission therapy for acute myelogenous leukemia in first complete remission

Eto, T., Takase, K., Miyamoto, T., Ohno, Y., Kamimura, T., Nagafuji, K., Takamatsu, Y., Teshima, T., Gondo, H., Taniguchi, S., Akashi, K. & Harada, M., Aug 1 2013, In : International journal of hematology. 98, 2, p. 186-196 11 p.

Research output: Contribution to journalArticle

4 Citations (Scopus)

High incidence and severity of injection site reactions in the first cycle compared with subsequent cycles of subcutaneous bortezomib

Kamimura, T., Miyamoto, T., Yokota, N., Aoki, T., Ito, Y. & Akashi, K., Dec 1 2013, In : International journal of hematology. 98, 6, p. 694-701 8 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)
2015

Preserved in vivo reconstitution ability of PBSCs cryopreserved for a decade at -80 °c

Shima, T., Iwasaki, H., Yamauchi, T., Kadowaki, M., Kiyosuke, M., Mochimaru, T., Takenaka, K., Miyamoto, T., Akashi, K. & Teshima, T., Sep 4 2015, In : Bone Marrow Transplantation. 50, 9, p. 1195-1200 6 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)
2012

Engulfment of hematopoietic stem cells caused by down-regulation of CD47 is critical in the pathogenesis of hemophagocytic lymphohistiocytosis

Kuriyama, T., Takenaka, K., Kohno, K., Yamauchi, T., Daitoku, S., Yoshimoto, G., Kikushige, Y., Kishimoto, J., Abe, Y., Harada, N., Miyamoto, T., Iwasaki, H., Teshima, T. & Akashi, K., Nov 8 2012, In : Blood. 120, 19, p. 4058-4067 10 p.

Research output: Contribution to journalArticle

29 Citations (Scopus)

Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: A multicenter phase II study

Ishida, T., Joh, T., Uike, N., Yamamoto, K., Utsunomiya, A., Yoshida, S., Saburi, Y., Miyamoto, T., Takemoto, S., Suzushima, H., Tsukasaki, K., Nosaka, K., Fujiwara, H., Ishitsuka, K., Inagaki, H., Ogura, M., Akinaga, S., Tomonaga, M., Tobinai, K. & Ueda, R., Mar 10 2012, In : Journal of Clinical Oncology. 30, 8, p. 837-842 6 p.

Research output: Contribution to journalArticle

379 Citations (Scopus)
2018

Comparison of antiemetic effects of granisetron and palonosetron in patients receiving bendamustine-based chemotherapy

Uchida, M., Nakamura, T., Makihara, Y., Suetsugu, K., Ikesue, H., Mori, Y., Kato, K., Shiratsuchi, M., Hosohata, K., Miyamoto, T. & Akashi, K., Jan 1 2018, In : Pharmazie. 73, 5, p. 304-308 5 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)
2015
6 Citations (Scopus)
2019

Evaluation of the compliance with antiemetic guidelines for prevention of chemotherapy-induced nausea and vomiting in patients with hematologic malignancy

Uchida, M., Nakamura, T., Shima, T., Mori, Y., Yoshimoto, G., Kato, K., Shimokawa, M., Hosohata, K., Miyamoto, T. & Akashi, K., Jan 1 2019, In : Pharmazie. 74, 4, p. 250-254 5 p.

Research output: Contribution to journalArticle

2014

Combination of bortezomib, thalidomide, and dexamethasone (VTD) as a consolidation therapy after autologous stem cell transplantation for symptomatic multiple myeloma in Japanese patients

Takashima, S., Miyamoto, T., Kadowaki, M., Ito, Y., Aoki, T., Takase, K., Shima, T., Yoshimoto, G., Kato, K., Muta, T., Shiratsuchi, M., Takenaka, K., Iwasaki, H., Teshima, T., Kamimura, T. & Akashi, K., Aug 2014, In : International journal of hematology. 100, 2, p. 159-164 6 p.

Research output: Contribution to journalArticle

4 Citations (Scopus)
2017

Identification of unipotent megakaryocyte progenitors in human hematopoiesis

Miyawaki, K., Iwasaki, H., Jiromaru, T., Kusumoto, H., Yurino, A., Sugio, T., Uehara, Y., Odawara, J., Daitoku, S., Kunisaki, Y., Mori, Y., Arinobu, Y., Tsuzuki, H., Kikushige, Y., Iino, T., Kato, K., Takenaka, K., Miyamoto, T., Maeda, T. & Akashi, K., Jun 22 2017, In : Blood. 129, 25, p. 3332-3343 12 p.

Research output: Contribution to journalArticle

16 Citations (Scopus)
2018

Prospective randomization of post-remission therapy comparing autologous peripheral blood stem cell transplantation versus high-dose cytarabine consolidation for acute myelogenous leukemia in first remission

For the Japan Study Group for Cell Therapy and Transplantation (JSCT), Apr 1 2018, In : International journal of hematology. 107, 4, p. 468-477 10 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)
2013

Efficacy and safety of aprepitant in allogeneic hematopoietic stem cell transplantation

Uchida, M., Kato, K., Ikesue, H., Ichinose, K., Hiraiwa, H., Sakurai, A., Muta, T., Takenaka, K., Iwasaki, H., Miyamoto, T., Teshima, T., Shiratsuchi, M., Suetsugu, K., Nagata, K., Egashira, N., Akashi, K. & Oishi, R., Sep 1 2013, In : Pharmacotherapy. 33, 9, p. 893-901 9 p.

Research output: Contribution to journalArticle

6 Citations (Scopus)
2012

Case of insulin edema occurring during intensive insulin therapy after bone marrow transplantation

Sugiyama, A., Takeuchi, S., Fukagawa, S., Moroi, Y., Yoshimoto, G., Miyamoto, T., Akashi, K. & Furue, M., Feb 1 2012, In : Journal of Dermatology. 39, 2, p. 172-175 4 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)
2013

Evaluation of the feasibility and efficacy of autologous stem cell transplantation in elderly patients with multiple myeloma

Muta, T., Miyamoto, T., Fujisaki, T., Ohno, Y., Kamimura, T., Kato, K., Takenaka, K., Iwasaki, H., Eto, T., Takamatsu, Y., Teshima, T. & Akashi, K., Jan 10 2013, In : Internal Medicine. 52, 1, p. 63-70 8 p.

Research output: Contribution to journalArticle

31 Citations (Scopus)
2019
2 Citations (Scopus)
2018
1 Citation (Scopus)
2013

Monitoring of minimal residual disease (MRD) is useful to predict prognosis of adult patients with Ph-negative ALL: Results of a prospective study (ALL MRD2002 Study)

Nagafuji, K., Miyamoto, T., Eto, T., Kamimura, T., Taniguchi, S., Okamura, T., Ohtsuka, E., Yoshida, T., Higuchi, M., Yoshimoto, G., Fujisaki, T., Abe, Y., Takamatsu, Y., Yokota, S., Akashi, K. & Harada, M., Feb 8 2013, In : Journal of Hematology and Oncology. 6, 1, 14.

Research output: Contribution to journalArticle

20 Citations (Scopus)
2016

Switching to nilotinib in patients with chronic myeloid leukemia in chronic phase with molecular suboptimal response to frontline imatinib: SENSOR final results and BIM polymorphism substudy

Miyamura, K., Miyamoto, T., Tanimoto, M., Yamamoto, K., Kimura, S., Kawaguchi, T., Matsumura, I., Hata, T., Tsurumi, H., Saito, S., Hino, M., Tadokoro, S., Meguro, K., Hyodo, H., Yamamoto, M., Kubo, K., Tsukada, J., Kondo, M., Aoki, M., Okada, H. & 3 others, Yanada, M., Ohyashiki, K. & Taniwaki, M., Dec 1 2016, In : Leukemia Research. 51, p. 11-18 8 p.

Research output: Contribution to journalArticle

7 Citations (Scopus)
2019

Anti-GPRC5D/CD3 bispecific T-cell-redirecting antibody for the treatment of multiple myeloma

Kodama, T., Kochi, Y., Nakai, W., Mizuno, H., Baba, T., Habu, K., Sawada, N., Tsunoda, H., Shima, T., Miyawaki, K., Kikushige, Y., Mori, Y., Miyamoto, T., Maeda, T. & Akashi, K., Jan 1 2019, In : Molecular Cancer Therapeutics. 18, 9, p. 1555-1564 10 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)

Prophylactic antiemetics for haematological malignancies: Prospective nationwide survey subset analysis in Japan

Yoshida, I., Tamura, K., Miyamoto, T., Shimokawa, M., Takamatsu, Y., Nanya, Y., Matsumura, I., Gotoh, M., Igarashi, T., Takahashi, T., Aiba, K., Kumagai, K., Ishizawa, K., Kurita, N., Usui, N. & Hatake, K., Jan 1 2019, In : In Vivo. 33, 4, p. 1355-1362 8 p.

Research output: Contribution to journalArticle

Open Access
2013

Effectiveness and safety of antiemetic aprepitant in japanese patients receiving high-dose chemotherapy prior to autologous hematopoietic stem cell transplantation

Uchida, M., Ikesue, H., Miyamoto, T., Kato, K., Suetsugu, K., Ichinose, K., Hiraiwa, H., Sakurai, A., Takenaka, K., Muta, T., Iwasaki, H., Teshima, T., Shiratsuchi, M., Egashira, N., Akashi, K. & Oishi, R., May 1 2013, In : Biological and Pharmaceutical Bulletin. 36, 5, p. 819-824 6 p.

Research output: Contribution to journalArticle

10 Citations (Scopus)
2017
3 Citations (Scopus)
2013

Decrease in venous irritation by adjusting the concentration of injected bendamustine

Watanabe, H., Ikesue, H., Tsujikawa, T., Nagata, K., Uchida, M., Suetsugu, K., Egashira, N., Muta, T., Kato, K., Takenaka, K., Ohga, S., Matsushima, T., Shiratsuchi, M., Miyamoto, T., Teshima, T., Akashi, K. & Oishi, R., Apr 1 2013, In : Biological and Pharmaceutical Bulletin. 36, 4, p. 574-578 5 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)
2018
2019

Cessation of nilotinib in patients with chronic myelogenous leukemia who have maintained deep molecular responses for 2 years: a multicenter phase 2 trial, stop nilotinib (NILSt)

Nagafuji, K., Matsumura, I., Shimose, T., Kawaguchi, T., Kuroda, J., Nakamae, H., Miyamoto, T., Kadowaki, N., Ishikawa, J., Imamura, Y., Yamazaki, H., Akashi, K. & Kanakura, Y., Dec 1 2019, In : International journal of hematology. 110, 6, p. 675-682 8 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Impact of High-Frequency HLA Haplotypes on Clinical Cytomegalovirus Reactivation in Allogeneic Hematopoietic Stem Cell Transplantation

HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation, Jan 1 2019, (Accepted/In press) In : Biology of Blood and Marrow Transplantation.

Research output: Contribution to journalArticle

2013

Impact of Graft-versus-Host Disease on Allogeneic Hematopoietic Cell Transplantation for Adult T Cell Leukemia-Lymphoma Focusing on Preconditioning Regimens: Nationwide Retrospective Study

Ishida, T., Hishizawa, M., Kato, K., Tanosaki, R., Fukuda, T., Takatsuka, Y., Eto, T., Miyazaki, Y., Hidaka, M., Uike, N., Miyamoto, T., Tsudo, M., Sakamaki, H., Morishima, Y., Suzuki, R. & Utsunomiya, A., Dec 1 2013, In : Biology of Blood and Marrow Transplantation. 19, 12, p. 1731-1739 9 p.

Research output: Contribution to journalArticle

28 Citations (Scopus)